サマリー

世界の坐骨神経痛治療市場 2022-2026
Technavioは坐骨神経痛治療市場を監視しており、2022-2026年の間に25億2000万ドルの成長が見込まれ、予測期間中にCAGR4.3％で減速する見通しとなっています。当レポートでは、坐骨神経痛治療市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、坐骨神経痛に対する意識の高まり、坐骨神経痛の危険因子の有病率の増加、パイプライン医薬品に対する規制当局のサポートによって牽引されています。
坐骨神経痛治療市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの坐骨神経痛治療市場は、以下のようにセグメント化されています。
タイプ別
- 非外科的治療
- 外科的治療
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、クロニジンマイクロペレット硬膜外注射の開発が、今後数年間の坐骨神経痛治療市場の成長を促進する主要な理由の1つであると特定しています。また、坐骨神経痛に関する研究資金の増加や、坐骨神経痛治療のための理学療法に対する認知度の向上も、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細なイメージを提示します。坐骨神経痛治療市場に関する当レポートは、以下の分野を対象としています。
- 坐骨神経痛治療市場のサイジング
- 坐骨神経痛治療市場の予測
- 坐骨神経痛治療市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Amneal Pharmaceuticals Inc、Apotex Inc、Aurobindo Pharma Ltd.、Bayer AG、Dr. Reddys Laboratories Ltd.、Fresenius SE and Co.KGaA、Glenmark Pharmaceuticals Ltd.、Hikma Pharmaceuticals Plc、Johnson and Johnson、Lupin Ltd.、Nidd Valley Medical、Novartis AG、Omega Laser Systems Ltd.、Ozone Pharmaceuticals Ltd.、Pfizer Inc、Sanofi、Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. および Viatris Inc.の各社が含まれています。また、坐骨神経痛治療市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sciatica-treatment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Non-surgical treatment - Market size and forecast 2021-2026
o Exhibit 28: Chart on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
o 5.4 Surgical treatment - Market size and forecast 2021-2026
o Exhibit 32: Chart on Surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Surgical treatment - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Surgical treatment - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Australia - Market size and forecast 2021-2026
o Exhibit 78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Australia - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Australia - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Apotex Inc.
o Exhibit 89: Apotex Inc. - Overview
o Exhibit 90: Apotex Inc. - Product / Service
o Exhibit 91: Apotex Inc. - Key offerings
o 10.4 Bayer AG
o Exhibit 92: Bayer AG - Overview
o Exhibit 93: Bayer AG - Business segments
o Exhibit 94: Bayer AG - Key offerings
o Exhibit 95: Bayer AG - Segment focus
o 10.5 Fresenius SE and Co. KGaA
o Exhibit 96: Fresenius SE and Co. KGaA - Overview
o Exhibit 97: Fresenius SE and Co. KGaA - Business segments
o Exhibit 98: Fresenius SE and Co. KGaA - Key news
o Exhibit 99: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 100: Fresenius SE and Co. KGaA - Segment focus
o 10.6 Glenmark Pharmaceuticals Ltd.
o Exhibit 101: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 102: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 103: Glenmark Pharmaceuticals Ltd. - Key offerings
o 10.7 Hikma Pharmaceuticals Plc
o Exhibit 104: Hikma Pharmaceuticals Plc - Overview
o Exhibit 105: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 106: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 107: Hikma Pharmaceuticals Plc - Segment focus
o 10.8 Johnson and Johnson
o Exhibit 108: Johnson and Johnson - Overview
o Exhibit 109: Johnson and Johnson - Business segments
o Exhibit 110: Johnson and Johnson - Key news
o Exhibit 111: Johnson and Johnson - Key offerings
o Exhibit 112: Johnson and Johnson - Segment focus
o 10.9 Novartis AG
o Exhibit 113: Novartis AG - Overview
o Exhibit 114: Novartis AG - Business segments
o Exhibit 115: Novartis AG - Key offerings
o Exhibit 116: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 117: Pfizer Inc. - Overview
o Exhibit 118: Pfizer Inc. - Product / Service
o Exhibit 119: Pfizer Inc. - Key news
o Exhibit 120: Pfizer Inc. - Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 121: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 122: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 123: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 Viatris Inc.
o Exhibit 126: Viatris Inc. - Overview
o Exhibit 127: Viatris Inc. - Business segments
o Exhibit 128: Viatris Inc. - Key offerings
o Exhibit 129: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 130: Inclusions checklist
o Exhibit 131: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 132: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 133: Research methodology
o Exhibit 134: Validation techniques employed for market sizing
o Exhibit 135: Information sources
o 11.5 List of abbreviations
o Exhibit 136: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Australia - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Australia - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Apotex Inc. - Overview
Exhibits90: Apotex Inc. - Product / Service
Exhibits91: Apotex Inc. - Key offerings
Exhibits92: Bayer AG - Overview
Exhibits93: Bayer AG - Business segments
Exhibits94: Bayer AG - Key offerings
Exhibits95: Bayer AG - Segment focus
Exhibits96: Fresenius SE and Co. KGaA - Overview
Exhibits97: Fresenius SE and Co. KGaA - Business segments
Exhibits98: Fresenius SE and Co. KGaA - Key news
Exhibits99: Fresenius SE and Co. KGaA - Key offerings
Exhibits100: Fresenius SE and Co. KGaA - Segment focus
Exhibits101: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits102: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits103: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits104: Hikma Pharmaceuticals Plc - Overview
Exhibits105: Hikma Pharmaceuticals Plc - Business segments
Exhibits106: Hikma Pharmaceuticals Plc - Key offerings
Exhibits107: Hikma Pharmaceuticals Plc - Segment focus
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Novartis AG - Overview
Exhibits114: Novartis AG - Business segments
Exhibits115: Novartis AG - Key offerings
Exhibits116: Novartis AG - Segment focus
Exhibits117: Pfizer Inc. - Overview
Exhibits118: Pfizer Inc. - Product / Service
Exhibits119: Pfizer Inc. - Key news
Exhibits120: Pfizer Inc. - Key offerings
Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits126: Viatris Inc. - Overview
Exhibits127: Viatris Inc. - Business segments
Exhibits128: Viatris Inc. - Key offerings
Exhibits129: Viatris Inc. - Segment focus
Exhibits130: Inclusions checklist
Exhibits131: Exclusions checklist
Exhibits132: Currency conversion rates for US$
Exhibits133: Research methodology
Exhibits134: Validation techniques employed for market sizing
Exhibits135: Information sources
Exhibits136: List of abbreviations